tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
Advertisement

Bright Minds Biosciences (DRUG) Ownership - Who Owns Bright Minds Biosciences?

Compare
253 Followers

Bright Minds Biosciences (DRUG) Ownership Overview

15.57%1.45%50.78%3.29%28.90%
15.57% Insiders
50.78% Other Institutional Investors
3.29% ETFs
28.90% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 55.52% of the company’s stock is owned by Institutional Investors, 15.57% is owned by Insiders, and 28.90% is owned by Public Companies and Individual Investors.
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. Approximately 52.24% of the company’s stock is owned by Institutional Investors, 15.57% is owned by Insiders, and 3.29% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 07, 2025
xxxxxxxxxxxxx
C$120960
Mar 07, 2025
xxxxxxxxxxxxx
$180985
Dec 11, 2024
xxxxxxxxxxxxx
C$1411795

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,004,900Insider14.18%58,173,661
449,290Institution6.34%26,009,398
206,427Institution2.91%11,950,059
164,201Institution2.32%9,505,596
57,600Insider0.81%3,334,464
49,131Institution0.69%2,844,194
40,822Institution0.58%2,363,186
28,308Institution0.40%1,638,750
25,960Institution0.37%1,502,824
20,609Insider0.29%1,193,055

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
49,131Institution0.69%2,844,194
25,960Institution0.37%1,502,824
11,604Institution0.16%671,756
5,987Institution0.08%346,587
3,856Institution0.05%223,224
1,870Institution0.03%108,254
1,390Institution0.02%80,467
896Institution0.01%51,869
600Institution<0.01%34,734
435Institution<0.01%25,182

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
21,942Institution0.31%1,331,002
11,455Institution0.16%689,018
4,015Institution0.06%243,550
3,058Institution0.04%258,102
472Institution<0.01%27,546
352Institution<0.01%21,352

FAQ

Who Owns Bright Minds Biosciences (DRUG)?
According to the latest TipRanks data, approximately 50.78% of the company's stock is held by institutional investors, 15.57% is held by insiders, and 28.90% is held by retail investors.
    What percentage of Bright Minds Biosciences (DRUG) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 50.78% of Bright Minds Biosciences (DRUG) stock is held by institutional investors.
      What percentage of Bright Minds Biosciences (DRUG) stock is held by retail investors?
      According to the latest TipRanks data, approximately 28.90% of Bright Minds Biosciences (DRUG) stock is held by retail investors.
        Who owns the most shares of Bright Minds Biosciences (DRUG)?
        Ian Mcdonald owns the most shares of Bright Minds Biosciences (DRUG).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis